Cancer and immunity: who is shaping whom?-Reference-Cited by-同舟云学术

Cancer and immunity: who is shaping whom?

Published:2021-07-20 Issue:5 Volume:40 Page:317-318
ISSN:0883-0185
Container-title:International Reviews of Immunology
language:en
Short-container-title:International Reviews of Immunology

Author:

Kumar Himanshu¹

Affiliation:

1. Editor-in-Chief, International Reviews of Immunology & Principal Investigator, Laboratory of Immunology and Infectious Disease Biology, Indian Institute of Science Education and Research (IISER), Bhopal, India

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08830185.2021.1946300

Reference4 articles.

1. IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer. Int Rev Immunol. 2021;40(5):319–329. doi:10.1080/08830185.202 1.1840565.

2. HLA-G expression in melanomas. Int Rev Immunol. 2021;40(5):330–343. doi:10.1080/08830185.202 1.1869732

3. Chemokines as the critical factors during bladder cancer progression: an overview. Int Rev Immunol. 2021;40(5):344–358. doi:10.1080/08830185.202 1.1877287

4. Immunology of HPV-mediated cervical cancer: current understanding. Int Rev Immunol. 2021;40(5):359–378. doi:10.1080/08830185.202 1.1811859

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance;Non-coding RNA Research;2024-06

2. Investigation into the in vivo mechanism of diosmetin in patients with breast cancer and COVID-19 using bioinformatics;Frontiers in Pharmacology;2022-08-17